Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.046; wR factor = 0.117; data-to-parameter ratio = 25.6.
Related literature
For general background, see: Brakhage (1998) ; Chenera et al. (1993) ; Ellis (1997); Farrugia (1997) ; Kilonda et al. (1995) ; Koojiman et al. (1984) ; Lampronti et al. (2003) . For bondlength data, see: Allen et al. (1987) . For ring conformation details, see: Cremer & Pople (1975) ; Nardelli (1983 
Data collection
Bruker Kappa APEXII diffractometer Absorption correction: multi-scan (Blessing, 1995) T min = 0.691, T max = 0.777 38750 measured reflections 9941 independent reflections 5805 reflections with I > 2(I) R int = 0.028 Refinement R[F 2 > 2(F 2 )] = 0.045 wR(F 2 ) = 0.116 S = 1.01 9941 reflections 389 parameters H-atom parameters constrained Á max = 0.79 e Å À3 Á min = À0.67 e Å À3 Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 3 2 ; y À 1 2 ; Àz þ 1 2 ; (ii) x þ 1 2 ; Ày þ 1 2 ; z À 1 2 .
Data collection: APEX2 (Bruker, 2004); cell refinement: APEX2; data reduction: SAINT (Bruker, 2004); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: PLATON (Spek, 2003) .
1-(4-Methoxyphenyl)-7-phenyl-3-(phenylselenylmethyl)perhydroisoxazolo[2',3':1,2]pyrrolo [3,4b]azetidine-6-spiro-2'-chroman-2,4'-dione E. T. S. Kamala, S. Nirmala, L. Sudha, N. Arumugam and R. Raghunathan
Comment
Chromanones are found to exhibit strong activity in inhibiting in vitro cell growth of human tumour cells (Lampronti et al., 2003) . Many chromanone derivatives are versatile intermediates for the synthesis of natural products such as brazillin, hematoxylin, ripariochromene, clausenin, calonlide A and inophyllum B (Koojiman et al.,1984; Ellis et al., 1997; Chenera et al., 1993) . Pyrrolidines and pyrroles are common structural motifs in drugs and drug candidates owing to their ability to act as selective glycosidase inhibitors which are used in the treatment of diabetes, cancer, malaria and viral infections including AIDS (Kilonda et al.,1995) . The most commonly used β-lactam antibiotics for the therapy of infectious diseases are penicillin and cephalosporin (Brakhage, 1998) . In view of the above, the crystal structure determination of the title compound was carried out and the results are presented here.
Bond lengths of the title compound ( Fig. 1) show normal values (Allen et al., 1987) . The pyrrolidine ring (N2/C4/C2/ C3/C5) adopts an envelope conformation with an asymmetry parameter (Nardelli,1983) ΔC s (N2) of 3.8 (2)° and puckering parameters (Cremer and Pople, 1975) of q 2 = 0.366 (2) Å and φ 2 = 184.9 (3)°. The oxazolidine ring (O2/N2/C5/C7/C6) is in a twist conformation with an asymmetry parameter ΔC 2 (O2) of 8.9 (2)° and puckering parameters q2 = 0.329 (2) Å and φ2 = 262.2 (3)°. The sums of bond angles around atom N1 (359.7°) and N2 (324.5°) indicate sp 2 and sp 3 hybridization, respectively. The tetrahydropyran ring adopts a half-chair conformation. The dihedral angle between the azetidinone ring and the attached methoxyphenyl ring is 15.7 (1)°.
In the crystal packing, intermolecular C-H···O interactions (Table 1) 
Experimental
To a solution of the bicyclic nitrone (1 mol) in dry acetonitrile (20 ml) was added 3-arylidene chromanone (1 mol) under a N 2 atmosphere. The reaction was refluxed for 4 h. After the completion of the reaction, the solvent was distilled off under reduced pressure and the crude product was purified by column chromatography. The title compound was crystallized from benzene solution by slow evaporation technique.
Refinement
H atoms were placed in idealized positions and allowed to ride on their parent atoms, with C-H = 0.93-0.98 Å and U iso (H)= 1.2-1.5U eq (C). Fig. 1 . The molecular structure of the title compound with 30% probability displacement ellipsoids. (9) 0.0317 (7) 0.0000 (7) 0.0052 (6) −0.0020 (6) N2 0.0373 (8) 0.0384 (9) 0.0318 (7) 0.0091 (7) 0.0030 (6) −0.0002 (6) C1 0.0366 (10) 0.0386 (11) 0.0324 (8) 0.0039 (8) 0.0002 (7) 0.0068 (8) C2 0.0367 (9) 0.0369 (11) 0.0337 (8) 0.0093 (8) 0.0030 (7) 0.0043 (8) C3 0.0426 (10) 0.0296 (9) 0.0343 (8) 0.0053 (8) 0.0064 (7) 0.0023 (7) C4 0.0346 (9) 0.0366 (10) 0.0320 (8) 0.0071 (8) 0.0037 (7) 0.0019 (7) C5 0.0356 (9) 0.0316 (10) 0.0368 (9) 0.0018 (7) 0.0043 (7) −0.0045 (7) C6 0.0291 (8) 0.0354 (10) 0.0319 (8) 0.0033 (7) −0.0003 (6) −0.0067 (7) C7 0.0290 (8) 0.0338 (10) 0.0346 (8) 0.0012 (7) 0.0026 (7) −0.0051 (7) C8 0.0329 (9) 0.0366 (10) 0.0359 (9) −0.0005 (8) −0.0018 (7) −0.0051 (8) C9
Figures
0.0328 (9) 0.0370 (11) 0.0370 (9) 0.0044 (8 
